MoneyWorks4Me

Syschem (India) informs about newspaper advertisements

28 Dec 2024 Evaluate

Syschem (India) has informed that the Company has published today the newspaper advertisements in the newspapers, Financial Express: (Delhi and Chandigarh in English) and Jansatta: (Hindi edition) with regards Extra Ordinary General Meeting (EGM) to be held through Video Conferencing/ other Audio Visual means only. Copy of the above notice as published in the newspapers is enclosed. The same is also available on the website of the Company at https://syschem.in/.

The above information is a part of company’s filings submitted to BSE.

Syschem (India) Share Price

32.30 0.28 (0.87%)
25-Aug-2026 11:13 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.95
Dr. Reddys Labs. 1186.00
Cipla 1418.00
Lupin 2171.50
Zydus Lifesciences 1097.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: